Anti-NES antibody-conjugated liposomes represent a promising advancement in glioma treatment, offering a novel approach to targeted drug delivery. By utilizing specific antibodies that recognize and bind to tumor cells, this system enhances the precision of drug distribution, ensuring that therapeutic agents directly reach the malignant cells while sparing healthy tissue. This targeted delivery not only boosts the overall effectiveness of the treatment but also minimizes adverse side effects commonly associated with traditional chemotherapy, paving the way for improved outcomes for patients with gliomas.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-1670z | Mouse Anti-NES Recombinant Antibody (clone 28C6) | WB, FC, ICC, IHC, IP | Mouse IgG1 |
MOB-1043MZ | Recombinant Mouse Anti-Human NES Antibody (clone 3D2.4B22) | FC, IP WB | Mouse antibody |
MRO-2064-CN | Rabbit Anti-NES Polyclonal Antibody (MRO-2064-CN) | IHC | Rabbit IgG |
MRO-2065-CN | Rabbit Anti-NES Polyclonal Antibody (MRO-2065-CN) | IF, IHC, FC, WB | Rabbit IgG |
VS3-CJ983 | Rabbit Anti-NES Recombinant Antibody (VS3-CJ983) | ICC, IF, IHC | Rabbit IgG |
There are currently no Customer reviews or questions for VS-1024-FY117. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.